ArticleCancers2026
RBX1
Qinwen Zuo, Ziheng Wang, Chengxiao Yang, Binghang Yan, Jiaming Li, Mingkai Cui, Meng Cai, Hongze Chen, Xuewei Bai
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Qinwen ZuoThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.ORCID 0009-0004-8716-8080 Ziheng WangThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Chengxiao YangThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Binghang YanThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Jiaming LiThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Mingkai CuiThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Meng CaiThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.ORCID 0009-0002-7861-7417 Hongze ChenThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Xuewei BaiThe Pancreatic Disease Diagnosis and Treatment Center, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Funding
National Natural Science Foundation of China 82573259Natural Science Foundation of Heilongjiang Province of China PL2024H67
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer-associated fibroblastspancreatic ductal adenocarcinomaRBX1Tenascin Ctumor microenvironment
Identifiers
PMID41899625
PMCPMC13025211
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390